APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor VII

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Selected research

Industry Growth & Trends

Global Human Coagulation Factor VII Industry Growth and Trends Forecast to 2032

26 December 202576 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor VII Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor VII Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor VII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor VII Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor VII Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Human Coagulation Factor VII market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Coagulation Factor VII market size, estimates, and forecasts are presented in terms of sales volume (K Mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Coagulation Factor VII market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Coagulation Factor VII.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Coagulation Factor VII market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Coagulation Factor VII Market by Company

NovoNordisk

Human Coagulation Factor VII Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Human Coagulation Factor VII Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Others

Human Coagulation Factor VII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Coagulation Factor VII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Factor VIII Table 2. Major Company of Plasma-derived Factor VIII Table 3. Global Human Coagulation Factor VII Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 5. Global Human Coagulation Factor VII Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Coagulation Factor VII Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Coagulation Factor VII Price by Type (2021-2026) & (USD/kg) Table 9. Global Human Coagulation Factor VII Sales by Type (2027-2032) & (K Mg) Table 10. Global Human Coagulation Factor VII Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Coagulation Factor VII Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Coagulation Factor VII Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Coagulation Factor VII Price by Type (2027-2032) & (USD/kg) Table 14. North America Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 15. North America Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 17. Europe Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 19. Asia-Pacific Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 21. Latin America Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Coagulation Factor VII Sales by Type (2021-2026) & (K Mg) Table 23. Middle East and Africa Human Coagulation Factor VII Sales by Type (2021-2026) & (US$ Million) Table 24. Human Coagulation Factor VII Industry Trends Table 25. Human Coagulation Factor VII Industry Drivers Table 26. Human Coagulation Factor VII Industry Opportunities and Challenges Table 27. Human Coagulation Factor VII Industry Restraints Table 28. Global Human Coagulation Factor VII Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Coagulation Factor VII Revenue Market Share by Company (2021-2026) Table 30. Global Human Coagulation Factor VII Sales by Company (2021-2026) & (K Mg) Table 31. Global Human Coagulation Factor VII Sales Share by Company (2021-2026) Table 32. Global Human Coagulation Factor VII Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Human Coagulation Factor VII Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Coagulation Factor VII Major Company Production Sites and Headquarters Table 35. Global Human Coagulation Factor VII Company, Product Type & Application Table 36. Global Human Coagulation Factor VII Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Coagulation Factor VII Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Coagulation Factor VII Sales by Region (2021-2026) & (K Mg) Table 41. Global Human Coagulation Factor VII Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Coagulation Factor VII Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Coagulation Factor VII Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Coagulation Factor VII Sales (K Mg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Human Coagulation Factor VII Sales by Region (2027-2032) & (K Mg) Table 46. Global Human Coagulation Factor VII Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Coagulation Factor VII Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Coagulation Factor VII Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Coagulation Factor VII Sales (K Mg), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Human Coagulation Factor VII Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 52. Global Human Coagulation Factor VII Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Coagulation Factor VII Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Coagulation Factor VII Price by Application (2021-2026) & (USD/kg) Table 56. Global Human Coagulation Factor VII Sales by Application (2027-2032) & (K Mg) Table 57. Global Human Coagulation Factor VII Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Coagulation Factor VII Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Coagulation Factor VII Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Coagulation Factor VII Price by Application (2027-2032) & (USD/kg) Table 61. North America Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 62. North America Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 64. Europe Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 66. Asia-Pacific Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 68. Latin America Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Coagulation Factor VII Sales by Application (2021-2026) & (K Mg) Table 70. Middle East and Africa Human Coagulation Factor VII Sales by Application (2021-2026) & (US$ Million) Table 71. NovoNordisk Company Information Table 72. NovoNordisk Business Overview Table 73. NovoNordisk Human Coagulation Factor VII Sales (K Mg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. NovoNordisk Human Coagulation Factor VII Product Portfolio Table 75. NovoNordisk Recent Development Table 76. North America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (K Mg): 2021 VS 2025 VS 2032 Table 77. North America Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 78. North America Human Coagulation Factor VII Sales Market Share by Country (2021-2026) Table 79. North America Human Coagulation Factor VII Sales Forecast by Country (2027-2032) & (K Mg) Table 80. North America Human Coagulation Factor VII Sales Market Share Forecast by Country (2027-2032) Table 81. North America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Human Coagulation Factor VII Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Human Coagulation Factor VII Market Share by Country (2021-2026) Table 84. North America Human Coagulation Factor VII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Human Coagulation Factor VII Market Share Forecast by Country (2027-2032) Table 86. Europe Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (K Mg): 2021 VS 2025 VS 2032 Table 87. Europe Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 88. Europe Human Coagulation Factor VII Sales Market Share by Country (2021-2026) Table 89. Europe Human Coagulation Factor VII Sales Forecast by Country (2027-2032) & (K Mg) Table 90. Europe Human Coagulation Factor VII Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Human Coagulation Factor VII Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Human Coagulation Factor VII Market Share by Country (2021-2026) Table 94. Europe Human Coagulation Factor VII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Human Coagulation Factor VII Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (K Mg): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 98. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Human Coagulation Factor VII Sales Forecast by Country (2027-2032) & (K Mg) Table 100. Asia-Pacific Human Coagulation Factor VII Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Human Coagulation Factor VII Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Human Coagulation Factor VII Market Share by Country (2021-2026) Table 104. Asia-Pacific Human Coagulation Factor VII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Human Coagulation Factor VII Market Share Forecast by Country (2027-2032) Table 106. Latin America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (K Mg): 2021 VS 2025 VS 2032 Table 107. Latin America Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 108. Latin America Human Coagulation Factor VII Sales Market Share by Country (2021-2026) Table 109. Latin America Human Coagulation Factor VII Sales Forecast by Country (2027-2032) & (K Mg) Table 110. Latin America Human Coagulation Factor VII Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Human Coagulation Factor VII Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Human Coagulation Factor VII Market Share by Country (2021-2026) Table 114. Latin America Human Coagulation Factor VII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Human Coagulation Factor VII Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (K Mg): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Human Coagulation Factor VII Sales by Country (2021-2026) & (K Mg) Table 118. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Human Coagulation Factor VII Sales Forecast by Country (2027-2032) & (K Mg) Table 120. Middle East and Africa Human Coagulation Factor VII Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Human Coagulation Factor VII Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Human Coagulation Factor VII Market Share by Country (2021-2026) Table 124. Middle East and Africa Human Coagulation Factor VII Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Human Coagulation Factor VII Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Human Coagulation Factor VII Distributors List Table 129. Human Coagulation Factor VII Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Human Coagulation Factor VII Image Figure 2. Global Human Coagulation Factor VII Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor VII Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor VII Sales (2021-2032) & (K Mg) Figure 5. Recombinant Factor VIII Image Figure 6. Global Recombinant Factor VIII Sales YoY Growth (2021-2032) & (K Mg) Figure 7. Plasma-derived Factor VIII Image Figure 8. Global Plasma-derived Factor VIII Sales YoY Growth (2021-2032) & (K Mg) Figure 9. Global Human Coagulation Factor VII Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Coagulation Factor VII Market Share by Type 2025 VS 2032 Figure 11. North America Human Coagulation Factor VII Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Coagulation Factor VII Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Coagulation Factor VII Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Coagulation Factor VII Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Coagulation Factor VII Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Coagulation Factor VII Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Coagulation Factor VII Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Coagulation Factor VII Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Coagulation Factor VII Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Coagulation Factor VII Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Coagulation Factor VII Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hemophilia A Image Figure 24. Global Hemophilia A Sales YoY Growth (2021-2032) & (K Mg) Figure 25. Spontanous / Trauma Image Figure 26. Global Spontanous / Trauma Sales YoY Growth (2021-2032) & (K Mg) Figure 27. Surgical Image Figure 28. Global Surgical Sales YoY Growth (2021-2032) & (K Mg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Mg) Figure 31. Global Human Coagulation Factor VII Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Coagulation Factor VII Market Share by Application 2025 VS 2032 Figure 33. North America Human Coagulation Factor VII Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Coagulation Factor VII Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Coagulation Factor VII Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Coagulation Factor VII Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Coagulation Factor VII Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Coagulation Factor VII Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Coagulation Factor VII Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Coagulation Factor VII Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Coagulation Factor VII Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Coagulation Factor VII Sales Market Share in Value by Application in 2025 Figure 43. North America Human Coagulation Factor VII Sales by Country: 2021 VS 2025 VS 2032 (K Mg) Figure 44. North America Human Coagulation Factor VII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Coagulation Factor VII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Coagulation Factor VII Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Coagulation Factor VII Sales by Country: 2021 VS 2025 VS 2032 (K Mg) Figure 48. Europe Human Coagulation Factor VII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Coagulation Factor VII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Coagulation Factor VII Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Coagulation Factor VII Sales by Country: 2021 VS 2025 VS 2032 (K Mg) Figure 52. Asia-Pacific Human Coagulation Factor VII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Coagulation Factor VII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Coagulation Factor VII Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Coagulation Factor VII Sales by Country: 2021 VS 2025 VS 2032 (K Mg) Figure 56. Latin America Human Coagulation Factor VII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Coagulation Factor VII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Coagulation Factor VII Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Coagulation Factor VII Sales by Country: 2021 VS 2025 VS 2032 (K Mg) Figure 60. Middle East and Africa Human Coagulation Factor VII Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Coagulation Factor VII Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Coagulation Factor VII Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Coagulation Factor VII Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Coagulation Factor VII Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Applications
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Others
Companies covered
  • NovoNordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Coagulation Factor VII Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Coagulation Factor VII Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Coagulation Factor VII Market by Type
  6. 1.3.1 Recombinant Factor VIII
  7. 1.3.2 Plasma-derived Factor VIII
  8. 1.4 Global Human Coagulation Factor VII Market Size by Type
  9. 1.4.1 Global Human Coagulation Factor VII Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Coagulation Factor VII Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Coagulation Factor VII Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Coagulation Factor VII Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Coagulation Factor VII Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Coagulation Factor VII Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Coagulation Factor VII Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Coagulation Factor VII Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Coagulation Factor VII Industry Trends
  2. 2.2 Human Coagulation Factor VII Industry Drivers
  3. 2.3 Human Coagulation Factor VII Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor VII Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Coagulation Factor VII Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Coagulation Factor VII Sales (2021-2026)
  3. 3.3 Global Top Players by Human Coagulation Factor VII Price (2021-2026)
  4. 3.4 Global Human Coagulation Factor VII Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor VII Major Company Production Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor VII Company, Product Type & Application
  7. 3.7 Global Human Coagulation Factor VII Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor VII Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor VII Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor VII Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor VII Regional Status and Outlook
  1. 4.1 Global Human Coagulation Factor VII Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Coagulation Factor VII Historic Market Size by Region
  3. 4.2.1 Global Human Coagulation Factor VII Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Coagulation Factor VII Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Coagulation Factor VII Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Coagulation Factor VII Forecasted Market Size by Region
  7. 4.3.1 Global Human Coagulation Factor VII Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Coagulation Factor VII Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Coagulation Factor VII Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Coagulation Factor VII by Application
  1. 5.1 Human Coagulation Factor VII Market by Application
  2. 5.1.1 Hemophilia A
  3. 5.1.2 Spontanous / Trauma
  4. 5.1.3 Surgical
  5. 5.1.4 Others
  6. 5.2 Global Human Coagulation Factor VII Market Size by Application
  7. 5.2.1 Global Human Coagulation Factor VII Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Human Coagulation Factor VII Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Human Coagulation Factor VII Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Human Coagulation Factor VII Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Human Coagulation Factor VII Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Human Coagulation Factor VII Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Human Coagulation Factor VII Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Human Coagulation Factor VII Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 NovoNordisk
  2. 6.1.1 NovoNordisk Company Information
  3. 6.1.2 NovoNordisk Business Overview
  4. 6.1.3 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 NovoNordisk Human Coagulation Factor VII Product Portfolio
  6. 6.1.5 NovoNordisk Recent Developments
7 North America by Country
  1. 7.1 North America Human Coagulation Factor VII Sales by Country
  2. 7.1.1 North America Human Coagulation Factor VII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Coagulation Factor VII Sales by Country (2021-2026)
  4. 7.1.3 North America Human Coagulation Factor VII Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Coagulation Factor VII Market Size by Country
  6. 7.2.1 North America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Coagulation Factor VII Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Coagulation Factor VII Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Coagulation Factor VII Sales by Country
  2. 8.1.1 Europe Human Coagulation Factor VII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Coagulation Factor VII Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Coagulation Factor VII Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Coagulation Factor VII Market Size by Country
  6. 8.2.1 Europe Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Coagulation Factor VII Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Coagulation Factor VII Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Coagulation Factor VII Sales by Country
  2. 9.1.1 Asia-Pacific Human Coagulation Factor VII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Coagulation Factor VII Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Coagulation Factor VII Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Coagulation Factor VII Market Size by Country
  6. 9.2.1 Asia-Pacific Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Coagulation Factor VII Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Coagulation Factor VII Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Coagulation Factor VII Sales by Country
  2. 10.1.1 South America Human Coagulation Factor VII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Coagulation Factor VII Sales by Country (2021-2026)
  4. 10.1.3 South America Human Coagulation Factor VII Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Coagulation Factor VII Market Size by Country
  6. 10.2.1 South America Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Coagulation Factor VII Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Coagulation Factor VII Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Coagulation Factor VII Sales by Country
  2. 11.1.1 Middle East and Africa Human Coagulation Factor VII Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Coagulation Factor VII Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Coagulation Factor VII Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Coagulation Factor VII Market Size by Country
  6. 11.2.1 Middle East and Africa Human Coagulation Factor VII Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Coagulation Factor VII Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Coagulation Factor VII Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Coagulation Factor VII Value Chain Analysis
  2. 12.1.1 Human Coagulation Factor VII Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Coagulation Factor VII Production Mode & Process
  7. 12.2 Human Coagulation Factor VII Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Coagulation Factor VII Distributors
  10. 12.2.3 Human Coagulation Factor VII Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst